On January 24, 2024, Establishment Labs Holdings Inc. closed the transaction. The company has now issued 1,101,565 common shares at a price of $25 per share for the gross proceeds of $27,539,125 and 898,435 warrants at a price of $24.999 per warrant for the gross proceeds of $22,459,976.565; for total gross proceeds of $49,999,101.565 pursuant to Regulation D. The transaction included participation from 10 investors.
Establishment Labs Holdings Inc.
Equities
ESTA
VGG312491084
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.96 USD | -1.53% | +5.92% | +116.15% |
08/05 | Transcript : Establishment Labs Holdings Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Establishment Labs Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+116.15% | 1.56B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 67.92B | |
+2.39% | 50.96B | |
+9.36% | 44.7B | |
+2.70% | 40.66B | |
+24.51% | 27.6B | |
+3.43% | 26.63B | |
-0.32% | 24.98B |
- Stock Market
- Equities
- ESTA Stock
- News Establishment Labs Holdings Inc.
- Establishment Labs Holdings Inc. announced that it has received $49.999102 million in funding